|
LATEST NEWS
UEHP
UEHP/SHAM workshop “What have we learnt from the health crisis to reinforce our resilience?”
Last 26 October, the European Union of Private Hospitals and SHAM Relyens (European mutual insurance company specialised in Risk management for healthcare) organised the workshop “What have we learnt from the health crisis to reinforce our resilience?”.
The event is part of a series of workshops on Risk management organised in close partenership with SHAM with the aim of creating a community of European experts on quality, safety of care and risk management.
The day was divided into a series of roundtables focusing on three main topics:
- workforce
- public/private partnerships
- Risk management in Covid19 times.
Speakers from all over Europe came to Brussels to exchange with the participants on those topics and to share experiences on how they managed their employees, the spaces in the hospitals, the new emerging risks, which partnerships were essential during the crisis, what did we learn from the pandemic, etc.
We had the privilege to have with us Mr Dirk Van den Steen, Deputy Head of Unit B1 in DG SANTE, who shared with us the European Commission's perspective and presented the work the Commission has done so far to support healthcare stakeholders during the pandemic and the new projects and initiatives for the future with a focus on the Recovery and Resilience Facilities.
A report of the works will be issued soon.
UEHP
UEHP hybrid Council meeting
Last 15 October, we held our first UEHP hybrid Council meeting in Brussels and online.
It was such an immense pleasure to welcome most UEHP members back again in our Brussels office after 22 months!
We had a packed agenda, inspiring discussions, new projects and the launch of our UEHP Factbook 2021. We also had the opportunity to hear from all our members about the situation of COVID-19 and vaccination in the different European countries. The pandemic is not over yet and private hospitals are still on the frontline in the fight against this invisible enemy.
Thank you to those who came to Brussels and those who stayed with us online for two days.
Private hospitals can be proud of the work done these past months. It is time now to prepare for the next steps and all the members are needed to build the future. See you very soon with new ideas and energies!
UEHP
UEHP visit to Lisbon
At the invitation of the Portuguese Association of Private Hospitals (APHP), UEHP President, Dr. Paul Garassus, had the privilege to meet with the Portuguese Health Minister, Marta Temido in Lisbon.
|
It was a cordial meeting where innovation and quality of care were discussed. UEHP conveyed the necessity of shifting the payment model towards quality of care and outcomes rather than quantity. Equal treatment and cooperation between health providers were also debated.
From left to right:
Oscar Gaspar, APHP President - Marta Temido Portuguese Health Minister - Dr. Paul Garassus, UEHP President
|
The President also met with Ana Rita Cavaco, President of the National Order of Nurses, who has kindly agreed to participate at the UEHP-SHAM workshop on Risk Management in Brussels.
|
Communication and collaboration between Health professionals, the current workforce shortages and the difficulties encountered by nurses before and during the pandemic were some of the issues addressed.
From left to right:
Oscar Gaspar, APHP President – Ana Rita Cavaco, President of the National Order of Nurses - Dr. Paul Garassus, UEHP President – Luís Filipe Barreira, Vice-president of the National Order of Nurses
|
|
During his visit to Lisbon, Dr. Garassus had also the great pleasure to meet Isabel Vaz, CEO of Luz Saúde, and visit Hospital da Luz Lisboa.
|
This remarkable and high-tech private establishment combines a highly differentiated hospital, a continued and palliative care unit, a general medicine centre, a residential home for the older population, and a Medical Simulation and Training Centre.
|
From left to right:
Dr. Paul Garassus, UEHP President– Isabel Vaz, CEO Luz Saúde - Oscar Gaspar, APHP President
Dialogue and cooperation among health professionals, stakeholders and health sectors are essential to build a healthier European Union. We thank APHP for making this visit possible.
EU
Commission Work Programme 2022
The European Commission has just released its 2022 Work Programme.
The Commission plans to deliver on its six main pillars:
- The European Green Deal/li>
- A Europe fit for the digital age
- An economy that works for people
- A stronger Europe in the world
- Promoting our European way of life
- A new push for European democracy
The top priorities for health are:
Cancer screening: Update of Recommendation on cancer screening (non-legislative, Q3)
Revision of the pharmaceutical legislation: legislative, incl. impact assessment, Q4.
The Work Programme and its annexes were adopted yesterday.
More information and full documents to download here.
EU
HaDEA, a new executive agency to help Europe’s recovery from COVID-19
|
A new executive agency for digital and health projects has been created in 2021 to help Europe emerge stronger from the COVID-19 pandemic. The European Health and Digital Executive Agency (HaDEA), is responsible for the implementation of relevant European Union (EU) financial programmes including the EU4Health programme, the Digital Europe programme and parts of the research and innovation programme, Horizon Europe.
|
The Health and Digital Executive Agency, also known as HaDEA, manages European programmes and initiatives on behalf of the European Commission. Its mission is to implement actions that strengthen Europe in the domains of health, food safety, digital technologies and networks, industrial capacities and space. HaDEA provides high quality and service-oriented support, with the aim to enable European society to become more healthy, resilient and fair; and European industry to become more competitive. We ensure that the projects funded by the HaDEA deliver concrete results that benefit the lives of all EU citizens and provide the European Commission with valuable input for its policies.
HaDEA addresses the European Commission’s ambition to help rebuild a post-COVID-19 Europe at its heart, which will be greener, more digital, more resilient and better fit for the current and forthcoming challenges. The expected total budget managed by HaDEA amounts to over €20 billion over the 7-year period of the 2021-2027 long term budget. In particular, the Agency is responsible for the management of parts of five European programmes: EU4Health, Food safety under the Single Market Programme, the Health and the Digital, Industry and Space Clusters under Horizon Europe, the Digital Europe Programme and the Digital part of the Connecting Europe Facility. In addition, it is responsible for the management of the ongoing projects funded by their predecessor programmes (2014-2020 long term budget).
Areas of funding are foreseen to help rebuild a post-COVID-19 Europe
Eu4Health is the EU’s response to the COVID-19 pandemic. The COVID-19 pandemic demonstrated the need for coordinated EU level action to respond to health emergencies. It revealed gaps in foresight, including demand/supply dimensions, preparedness and response tools, as well as weaknesses in health systems. That is why the European Commission is building a Health Union that is both better prepared and addresses long-term challenges such as disease prevention including cancer, access to medicines, and digitalisation among others. The EU4Health Programme provides an unprecedented level of funding: €5.3 billion from 2021-2027. The four overall objectives are:
- To improve and foster health in the Union
- To tackle cross-border health threats
- To improve medicinal products, medical devices and crisis-relevant products
- To strengthen health systems, their resilience and resource efficiency
HaDEA is implementing the EU4Health annual work programmes. The 2021 work programme includes actions falling under four strands: disease prevention, crisis preparedness, health systems, and digital, with a cross-cutting focus on cancer. The programme provides funding among others to EU countries, health organisations and NGOs. The programme strives to address challenges related to health promotion and disease prevention as well as diagnosis and therapies for cancer, and supports Member States in dealing with cross-border health threats. EU4Health also supports actions related to the availability of and access to medical products and making healthcare systems more resilient, sustainable and efficient, including advancing on their digital transformation.
Types of initiatives from the hospital sector would be most valuable to help rebuild a post-COVID-19 Europe
As hospitals were and still are at the forefront of the Covid-19 pandemic, they are an essential stakeholder to the Programme. The Commission organises extensive outreach activities with stakeholders to ensure that the views and needs of civil society are duly represented and taken into account. For instance, before the summer, the Commission gathered the views of stakeholders on priorities, strategy & needs in view of the preparation of the Annual Work programme 2022 of the EU4Health programme and beyond.
The priorities define the funding opportunities that are published every year through the financing decision, which is the annual work programmes. We warmly encourage applicants to read carefully the Annual Work Programme to seek funding opportunities. Those are available through the Funding and Tenders Portal. While preparing their proposal, applicants need to consider that the actions implemented need to have an EU added value.
Useful links:
Programmes are specifically dedicated to hospitals and the health sector
To face health threats, access to medicines, medical devices and other health supplies is not sufficient. A strong healthcare workforce, equipped with the necessary skills is also needed. In that sense, EU4Health will for instance, support healthcare workforce training in specific areas. Applicants are strongly encouraged to contact their National Focal Points (NFP). NFPs are the national experts for the Health Programme in EU countries and participating countries and they are appointed by their national health ministries. Their role is to assist in Health Programme implementation at national level; Health Programme dissemination of results and information on the impact generated by the Health Programme in their respective countries.
Useful links
From a research and innovation perspective, HaDEA also implements the Horizon Europe Programme, and specifically Cluster 1 ‘Health’ which aims to mainly contribute to four impact areas of the strategic plan: A good health and high-quality accessible healthcare; a resilient and prepared EU for emerging threats; high quality digital services for all and a competitive and secure data-economy.
More specifically, cluster 1 aims to contribute to six expected impacts as set by the strategic plan, which are the destinations of this work programme:
- Destination 1: Staying healthy in a rapidly changing society
- Destination 2: Living and working in a health-promoting environment
- Destination 3: Tackling diseases and reducing disease burden
- Destination 4: Ensuring access to innovative, sustainable and high-quality health care
- Destination 5: Unlocking the full potential of new tools, technologies and digital solutions for a healthy society
- Destination 6: Maintaining an innovative, sustainable and globally competitive health industry
The Horizon Europe Health cluster is mainly implemented through annual calls for proposals for Research and Innovation Actions (RIA), Innovation Actions (IA), Cofund actions, Coordination and Support Actions (CSA), pre-commercial procurement (PCP) actions and public procurement of innovative solutions (PPI), as well as emergency calls for Expressions of Interest in response to emergencies.
Useful links
EU
Public consultation on the revision of the EU's pharmaceutical legislation
The European Commission has published a public consultation on the revision of the EU's pharmaceutical legislation.
This public consultation aims to collect views of stakeholders and the general public in order to support the evaluation of the existing general pharmaceutical legislation on medicines for human use, and the impact assessment of its revision to ensure a future-proof and crisis-resistant medicines regulatory system.
It builds further on the public consultation conducted for the preparation of the Pharmaceutical Strategy for Europe of November 2020. The general pharmaceutical legislation sets the main definitions, regulatory incentives and authorization procedures, as well as the manufacturing, authorization and post-authorization requirements for medicines.
The consultation, which will run for twelve weeks, until 21 December, will gather the views from both the general public and stakeholders to support the evaluation of and the impact assessment for the revision of the EU's pharmaceutical legislation.
A major flagship action of the Strategy is the revision of the general pharmaceutical legislation, foreseen for end 2022, which is also being supported by an ongoing study. Other flagship actions of the Strategy focus on Health Technology Assessment, EU Health Data Space, legislation on rare diseases and medicines for children and strengthening the continuity and security of supply of medicines in the EU.
|